HOLZMINDEN, GERMANY and ÅLESUND, NORWAY — Symrise AG recently signed a strategic partnership with Hofseth BioCare ASA (HBC), a Norwegian producer of salmon-based ingredients for the human and pet nutrition markets. According to Symrise, the partnership will help expand its presence in the health category with clinically proven marine ingredients, as well as complement its current ingredient portfolio. 

Founded in 2009, HBC upcycles side streams from the salmon industry, taking fresh filleted salmon and transforming it from waste product into human-grade ingredients to enhance human and pet health. 

As part of the partnership, HBC plans to refurbish its Berkak, Norway, facility into a state-of-the-art enzymatic hydrolysis plant that is expected to triple its production. Symrise and HBC will use the facility to explore new products. Additionally, Symrise will leverage its go-to-market strategy to promote HBC’s products throughout the globe. 

“This partnership with HBC is testament to their unique footprint and differentiated science,” said Jean-Yves Parisot, DVM, chief executive officer of Symrise. “Their investments in clinical studies demonstrate proven benefits in key categories of metabolic health, immune health, gut health and mobility, setting them apart. This partnership is well aligned with our willingness to accelerate in health in the context of our ‘One Care’ journey but also with the recent creation of the Global Marine Platform to explore the vast potential that the oceans could offer us.”

According to the companies’, the partnership will help enhance public awareness of the health value of marine ingredients and further HBC’s position as a leader in science-led, marine nutrition.

“Symrise has been a key partner for us already and we are very excited to move ahead as they will help transform our scale and market access with their well-established market presence,” said Jon Olav Odegard, CEO of HBC. “The human health and premium pet markets continue to grow very strongly, and this partnership will allow us to sustain our growth trajectory and position us as the leading player in the science-led marine nutrition segment dedicated to human health.”

Read more news from pet food and treat industry suppliers.